Moving forward with actionable therapeutic targets and opportunities in endometrial cancer: NCI clinical trials planning meeting report on identifying key genes and molecular pathways for targeted endometrial cancer trials

The incidence and mortality rates from endometrial cancer are increasing. There have been no new drugs approved for the treatment of endometrial cancer in decades. The National Cancer Institute, Gynecologic Cancer Steering Committee identified the integration of molecular and/or histologic stratific...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: MacKay, Helen J., Levine, Douglas A., Bae-Jump, Victoria L., Bell, Daphne W., McAlpine, Jessica N., Santin, Alessandro, Fleming, Gini F., Mutch, David G., Nephew, Kenneth P., Wentzensen, Nicolas, Goodfellow, Paul J., Dorigo, Oliver, Nijman, Hans W., Broaddus, Russell, Kohn, Elise C.
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2017
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5663622/
https://ncbi.nlm.nih.gov/pubmed/29137450
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.19961
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados